Showing 16,721 - 16,740 results of 31,994 for search '(( 50 ((we decrease) OR (((mean decrease) OR (a decrease)))) ) OR ( a step decrease ))', query time: 0.62s Refine Results
  1. 16721

    Shifting Baselines in Antarctic Ecosystems; Ecophysiological Response to Warming in <em>Lissarca miliaris</em> at Signy Island, Antarctica by Adam J. Reed (109230)

    Published 2012
    “…Using material collected from the 1970's to the present day, we show an increase in growth rate and adult shell deterioration accompanied by a decrease in offspring size, associated with an increase in annual average temperatures. …”
  2. 16722

    Intracellular GSH and GSH/GSSG ratio in monolayer cultures upon induced oxidative stress. by Mireille M. J. P. E. Sthijns (12245491)

    Published 2022
    “…<p>A) Exposing the monolayer cultures of 0:100, 50:50 and 100:0 INS1E:alphaTC1 cells to 500 μM H<sub>2</sub>O<sub>2</sub> only induced a significant decrease in intracellular GSH compared to a monolayer culture not exposed to H<sub>2</sub>O<sub>2</sub> in the ratios of 50:50 and 0:100 INS1E:alphaTC1. …”
  3. 16723

    The disorganized nature of SP8<sup>+</sup> interneurons in GL and the expression level of SP8<sup>+</sup> interneurons. by Zhenzu Li (3108309)

    Published 2016
    “…Lgl1 conditional mice exhibited severe disorganization in OB interneurons and an almost complete loss of interneurons in the GL at P21. There was a noticeable decrease of SP8<sup>+</sup> interneurons in the GL of Lgl1 mutants (f<sup>,</sup>) compared to WT controls (f). …”
  4. 16724

    Effects of chronic clenbuterol treatment on intact muscle contractile properties. by Pascal Sirvent (589813)

    Published 2014
    “…<b>B,</b> Recordings show the decrease in tension resulting from the fatigue protocol in control EDL muscles (CTR) in which T<sub>lim</sub> was almost 50 s and in clenbuterol treated EDL muscles (CLB) in which T<sub>lim</sub> was about 34 s. …”
  5. 16725

    Selective cytotoxicity of AQHAR in human cancer cells. by Kejuan Li (2580184)

    Published 2016
    “…Human osteosarcoma (U2OS) cells showed dose-dependent decrease in viability; normal fibroblasts (TIG-3) were not affected by the equivalent doses (B) Phase contrast images of human cancer and normal cells showing toxicity of AQHAR (50 μg/ml) to cancer cells only. …”
  6. 16726

    Artemisinin Inhibits Yeast Respiratory Growth by Depolarizing the Mitochondrial Membrane by Wei Li (7081)

    Published 2013
    “…The peak shift toward the left represents a decrease of fluorescence signal indicating the loss of membrane potential. …”
  7. 16727
  8. 16728

    ELMO1 Is Upregulated in AML CD34+ Stem/Progenitor Cells, Mediates Chemotaxis and Predicts Poor Prognosis in Normal Karyotype AML by Marta E. Capala (652765)

    Published 2014
    “…Finally, ELMO1 depletion caused a marked decrease in SDF1-induced chemotaxis of leukemic cells. …”
  9. 16729

    Mitochondrial fatty acid uptake and complex IV inhibition by palmitoylcarnitine in early type-2 diabetic hearts. by Phing-How Lou (198977)

    Published 2014
    “…N = 5–6 hearts per group. Data are or mean ± SD (panels A) or mean ± SEM (panel B).</p>…”
  10. 16730

    The probability of tumor nodule eradication increases with the increase of CTL number. by Claire Christophe (714134)

    Published 2015
    “…Other lines: same evolution when the mean killing time is decreased by 10%, 50% and 90%. …”
  11. 16731

    The Effect of Ligand Lipophilicity on the Nanoparticle Encapsulation of Pt(IV) Prodrugs by Timothy C. Johnstone (1312911)

    Published 2013
    “…As the platinum concentration was increased, there was an initial increase in encapsulation followed by a decrease due to macroscopic precipitation. Maximal loading occurred when the platinum complex was present at a 40% w/w ratio with respect to polymer during the nanoprecipitation step. …”
  12. 16732

    Overexpression of miR-105 inhibits tumour cell growth but does not induce apoptosis. by D. Rice Honeywell (442714)

    Published 2013
    “…<p>(A–B) Tumour cells were transfected with either 50 nM miR-105 (closed squares) or control (open circles) mimics and subsequently seeded into 96-well plates in replicates of 8. …”
  13. 16733

    Image2_Peripheral blood T-cell modulation by omalizumab in chronic urticaria patients.jpeg by Cristina López (2841392)

    Published 2024
    “…</p>Results<p>In patients with CSU under treatment with omalizumab, there was a significant decrease in the percentage of naïve and an increase in the percentage of central memory CD4 T cells as well as a decrease in the percentage of naïve and increase in the percentage of effector CD8 T-cell subsets. …”
  14. 16734

    Image1_Peripheral blood T-cell modulation by omalizumab in chronic urticaria patients.jpeg by Cristina López (2841392)

    Published 2024
    “…</p>Results<p>In patients with CSU under treatment with omalizumab, there was a significant decrease in the percentage of naïve and an increase in the percentage of central memory CD4 T cells as well as a decrease in the percentage of naïve and increase in the percentage of effector CD8 T-cell subsets. …”
  15. 16735

    Table4_Peripheral blood T-cell modulation by omalizumab in chronic urticaria patients.docx by Cristina López (2841392)

    Published 2024
    “…</p>Results<p>In patients with CSU under treatment with omalizumab, there was a significant decrease in the percentage of naïve and an increase in the percentage of central memory CD4 T cells as well as a decrease in the percentage of naïve and increase in the percentage of effector CD8 T-cell subsets. …”
  16. 16736

    Image3_Peripheral blood T-cell modulation by omalizumab in chronic urticaria patients.pdf by Cristina López (2841392)

    Published 2024
    “…</p>Results<p>In patients with CSU under treatment with omalizumab, there was a significant decrease in the percentage of naïve and an increase in the percentage of central memory CD4 T cells as well as a decrease in the percentage of naïve and increase in the percentage of effector CD8 T-cell subsets. …”
  17. 16737

    Table3_Peripheral blood T-cell modulation by omalizumab in chronic urticaria patients.docx by Cristina López (2841392)

    Published 2024
    “…</p>Results<p>In patients with CSU under treatment with omalizumab, there was a significant decrease in the percentage of naïve and an increase in the percentage of central memory CD4 T cells as well as a decrease in the percentage of naïve and increase in the percentage of effector CD8 T-cell subsets. …”
  18. 16738

    Image4_Peripheral blood T-cell modulation by omalizumab in chronic urticaria patients.pdf by Cristina López (2841392)

    Published 2024
    “…</p>Results<p>In patients with CSU under treatment with omalizumab, there was a significant decrease in the percentage of naïve and an increase in the percentage of central memory CD4 T cells as well as a decrease in the percentage of naïve and increase in the percentage of effector CD8 T-cell subsets. …”
  19. 16739

    Table2_Peripheral blood T-cell modulation by omalizumab in chronic urticaria patients.docx by Cristina López (2841392)

    Published 2024
    “…</p>Results<p>In patients with CSU under treatment with omalizumab, there was a significant decrease in the percentage of naïve and an increase in the percentage of central memory CD4 T cells as well as a decrease in the percentage of naïve and increase in the percentage of effector CD8 T-cell subsets. …”
  20. 16740

    Table1_Peripheral blood T-cell modulation by omalizumab in chronic urticaria patients.docx by Cristina López (2841392)

    Published 2024
    “…</p>Results<p>In patients with CSU under treatment with omalizumab, there was a significant decrease in the percentage of naïve and an increase in the percentage of central memory CD4 T cells as well as a decrease in the percentage of naïve and increase in the percentage of effector CD8 T-cell subsets. …”